Search results
New treatment may extend survival for people with advanced colon cancer
UPI· 6 days agoPeople battling advanced colon cancers might have a new treatment option that could extend their...
Study supports watch-and-wait approach to slow-growing prostate cancer
UPI· 5 days agoFor a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors...
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 1 day agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
KOLR - KSFX Ozarks· 3 days agoEli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in patients with KRAS G12C-mutant advanced solid tumors ...
...Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...
Morningstar· 3 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and ...
New research platform assesses brain cancer mutati | Newswise
Newswise· 6 days agoJACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
ThePress.net· 3 days ago...01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that results from the pivotal Phase 2 TRUST-I study...
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 4 days agoScientists have hailed the drug, called lorlatinib, for its “off the charts” results after a trial...
Craniotomy vs. Craniectomy: Symptoms, Causes, and Treatment
Healthline· 4 days agoA craniotomy and craniectomy are two types of surgeries that involve removing a flap of bone from...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 11 hours ago“If approved in Europe, patients will have the option to be treated with Tagrisso alone, or with...